Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting
arcticnovartis
- Shareholders approved 28th consecutive dividend increase to CHF 3.50 (+6.1%) per share for 2024, representing a 3.5% yield¹
- Shareholders elected Giovanni Caforio as new member and Chair of the Board of Directors as well as Elizabeth McNally as new member of the Board of Directors. Joerg Reinhardt, Charles L. Sawyers and William T. Winters did not stand for re-election